2,116 results on '"Pol Stanislas"'
Search Results
2. Real-world effectiveness and safety of bulevirtide monotherapy for up to 96 weeks in patients with HDV-related cirrhosis
3. Patient and physician expectations regarding disease and treatment of advanced HCC: The prospective PERCEPTION1 study
4. Impact of HCV cure on subsequent hospitalizations in people with mental disorders: Results from the French claims database
5. Impaired health-related quality of life in the HCV cure era: who is concerned? (ANRS CO22 HEPATHER French cohort)
6. Effect of Peg-IFN on the viral kinetics of patients with HDV infection treated with bulevirtide
7. Treatment with bulevirtide in HIV-infected patients with chronic hepatitis D: ANRS HD EP01 BuleDelta and compassionate cohort
8. Prospective head-to-head comparison of non-invasive scores for diagnosis of fibrotic MASH in patients with type 2 diabetes
9. Direct-Acting Antivirals and the Risk of Arrhythmias and Conduction Disorders in Patients with Chronic Hepatitis C: A French Nationwide Cohort Study
10. Hepatitis D Virus Infection Markedly Increases the Risk of Hepatocellular Carcinoma in Patients with Viral B Cirrhosis
11. Alcohol Rehabilitation Within 3 Months After Alcohol Hepatitis and Survival - A National Analysis
12. Hepatitis C virus-specific cellular immune responses in individuals with no evidence of infection
13. Unknown Circovirus in Immunosuppressed Patient with Hepatitis, France, 2022
14. Hepatic profile analyses of tipranavir in Phase II and III clinical trials
15. Burden of grade 3 or 4 liver injury associated with immune checkpoint inhibitors
16. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area: What's new 12 months later?
17. Low alcohol consumption influences outcomes in individuals with alcohol-related compensated cirrhosis in a French multicenter cohort
18. Integrating genetic variants into clinical models for hepatocellular carcinoma risk stratification in cirrhosis
19. Diversity of the nucleic acid forms of circulating HBV in chronically infected patients and its impact on viral cycle
20. Executive Summary of the KDIGO 2022 Clinical Practice Guideline for the Prevention, Diagnosis, Evaluation, and Treatment of Hepatitis C in Chronic Kidney Disease
21. Effectiveness and safety of glecaprevir/pibrentasvir for 8 weeks in the treatment of patients with acute hepatitis C: A single-arm retrospective study.
22. Early IFNβ secretion determines variable downstream IL-12p70 responses upon TLR4 activation
23. Severe liver fibrosis in the HCV cure era: Major effects of social vulnerability, diabetes, and unhealthy behaviors
24. Prediction of hepatocellular carcinoma in Hepatitis C patients with advanced fibrosis after sustained virologic response
25. Characteristics of hepatitis C virus resistance in an international cohort after a decade of direct-acting antivirals
26. Elevated coffee consumption is associated with a lower risk of elevated liver fibrosis biomarkers in patients treated for chronic hepatitis B (ANRS CO22 Hepather cohort)
27. Impact of extending direct antiviral agents (DAA) availability in France: an observational cohort study (2015-2019) of data from French administrative healthcare databases (SNDS).
28. Burden of liver disease progression in hospitalized patients with type 2 diabetes mellitus
29. External Validation of LCR1-LCR2, a Multivariable Hepatocellular Carcinoma Risk Calculator, in a Multiethnic Cohort of Patients With Chronic Hepatitis B
30. Early hepatocellular carcinoma detection using magnetic resonance imaging is cost-effective in high-risk patients with cirrhosis
31. Prognosis of French COVID-19 patients with chronic liver disease: A national retrospective cohort study for 2020
32. Clinical outcomes after treatment with direct antiviral agents: beyond the virological response in patients with previous HCV-related decompensated cirrhosis
33. Cannabis use as a factor of lower corpulence in hepatitis C-infected patients: results from the ANRS CO22 Hepather cohort
34. Predictive factors for hepatocellular carcinoma in chronic hepatitis B using structural equation modeling: a prospective cohort study
35. External validation of LCR1-LCR2, a multivariable HCC risk calculator, in patients with chronic HCV
36. Differential levels of IFNα subtypes in autoimmunity and viral infection
37. Treatment of hepatitis C virus infection
38. Impact of cirrhosis aetiology on incidence and prognosis of hepatocellular carcinoma diagnosed during surveillance
39. Including Ratio of Platelets to Liver Stiffness Improves Accuracy of Screening for Esophageal Varices That Require Treatment
40. Impact of COVID-19 on the management of hepatocellular carcinoma in a high-prevalence area
41. Absence of impact of direct acting antivirals for hepatitis C virus on recurrent hepatocellular carcinoma tumor growth in the AFEF/ANRS CO22 Hepather cohort
42. Increased mortality in HIV/HCV-coinfected compared to HCV-monoinfected patients in the DAA era due to non-liver-related death
43. Personalized surveillance for hepatocellular carcinoma in cirrhosis – using machine learning adapted to HCV status
44. Selonsertib for patients with bridging fibrosis or compensated cirrhosis due to NASH: Results from randomized phase III STELLAR trials
45. Bulevirtide Combined with Pegylated Interferon for Chronic Hepatitis D
46. WED-245 Should specific cutoffs be used for diagnosing fibrotic MASH in patients with type 2 diabetes using FAST, MAST, MEFIB and FNI?
47. GS-002 48-week off-therapy efficacy and safety of bulevirtide in combination with pegylated interferon alfa-2a in patients with chronic hepatitis delta: final results from the phase 2b, open-label, randomised, multicentre study MYR204
48. FRI-361 Burden of liver disease progression in patients with chronic HDV infection: a population-based study for France
49. FRI-371 Undetectable HDV RNA at 24 weeks of treatment with combination therapy is an important predictor of maintained response off-therapy
50. WED-410 Sustained virological response after treatment with Bulevirtide in HDV patients. Data from the french multicenter real-life cohort
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.